Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Astrocytoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 2)
Glioblastoma (Phase 1)
Head and Neck Neoplasms (Phase 1)
Lung Neoplasms (Phase 1/Phase 2)
Medulloblastoma (Phase 1)
Melanoma (Phase 2)
Microsatellite Instability (Phase 1)
Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue